首页> 外文OA文献 >Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality
【2h】

Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality

机译:22个欧洲国家的睾丸癌发病率和死亡率趋势:发病率持续上升和死亡率下降

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study profiles testicular cancer incidence and mortality across Europe, and the effects of age, period and generational influences, using age-period-cohort modeling. Despite a 5-fold variation in incidence rates, there were consistent mean increases in incidence in each of the 12 European countries studied, ranging from around 6% per annum (Spain and Slovenia) to 1-2% (Norway). In contrast, declines in testicular cancer mortality of 3-6% per annum were observed in the 1980s and 1990s for the majority of the 22 countries studied, particularly in Northern and Western Europe. The mortality trends in several European countries were rather stable (Romania and Bulgaria) or increasing (Portugal and Croatia). Short-term attenuations in increasing cohort-specific risk of incidence were indicated among men born between 1940 and 1945 in 7 European countries. In Switzerland, successive generations born from the mid 1960s may have experienced a steadily declining risk of disease occurrence. While the underlying risk factors responsible remain elusive, the temporal and geographical variability in incidence may point to an epidemic in different phases in different countries-the result of country-specific differences in the prevalence of one or several ubiquitous and highly prevalent environmental determinants of the disease. Advances in treatment have led to major declines in mortality in many European countries from the mid 1970s, which has translated to cohorts of men at successively lower risk of death from the disease. Slower progress in the delivery of optimal care is however evident from the mortality trends in several lower-resource countries in Southern and Eastern Europe. The first beneficiaries of therapy in these populations may be those men born--rather than diagnosed--in the era of major breakthrough in testicular cancer care. Copyright 2006 Wiley-Liss, Inc.
机译:这项研究使用年龄-年龄-队列模型分析了整个欧洲睾丸癌的发病率和死亡率,以及年龄,时期和世代影响的影响。尽管发病率变化了5倍,但是在所研究的12个欧洲国家中,发病率的平均增长率一直保持稳定,从每年6%(西班牙和斯洛文尼亚)到1-2%(挪威)不等。相反,在1980年代和1990年代,在所研究的22个国家中,大多数国家,尤其是在北欧和西欧,每年睾丸癌死亡率下降了3-6%。欧洲几个国家的死亡率趋势相当稳定(罗马尼亚和保加利亚)或呈上升趋势(葡萄牙和克罗地亚)。在19个欧洲国家中,1940年至1945年之间出生的男性中,出现队列特定人群的发病风险增加的短期趋势有所减轻。在瑞士,从1960年代中期开始出生的子孙后代可能会经历疾病发生的风险不断下降的情况。尽管所负责的潜在风险因素仍然难以捉摸,但发病率的时间和地理变异性可能表明不同国家在不同阶段的流行病-这是该国一个或几个普遍存在且高度流行的环境决定因素的流行率因国家而异的结果。疾病。自1970年代中期以来,治疗的进步已导致许多欧洲国家的死亡率大幅度下降,这已转化为成群的男性,因这种疾病而死亡的风险逐渐降低。然而,从南欧和东欧一些资源较少的国家的死亡率趋势可以明显看出,在提供最佳护理方面进展缓慢。在这些人群中,治疗的第一个受益者可能是那些在睾丸癌治疗取得重大突破的时代出生的人,而不是被诊断出的人。版权所有2006 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号